MBP and myeloid sarcoma: Additionally, increasing MLKL and GFAP (a marker for CNS injury) protein levels alongside decreasing MBP, corresponding to the increasing disease score for EAE mice depicting the MS state, reinforced the dysregulation of the MLKL‒OPTN axis.